Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does APREPITANT Cause Atelectasis? 125 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Atelectasis have been filed in association with APREPITANT (CINVANTI). This represents 2.2% of all adverse event reports for APREPITANT.

125
Reports of Atelectasis with APREPITANT
2.2%
of all APREPITANT reports
5
Deaths
124
Hospitalizations

How Dangerous Is Atelectasis From APREPITANT?

Of the 125 reports, 5 (4.0%) resulted in death, 124 (99.2%) required hospitalization, and 5 (4.0%) were considered life-threatening.

Is Atelectasis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 125 reports have been filed with the FAERS database.

What Other Side Effects Does APREPITANT Cause?

Fatigue (955) Pyrexia (913) Dyspnoea (909) Hypersensitivity (881) Rash (789) Alopecia (760) Gastrointestinal disorder (722) Pruritus (707) Confusional state (696) Glossodynia (696)

What Other Drugs Cause Atelectasis?

PREDNISONE (446) ALBUTEROL (317) METHOTREXATE (307) CYCLOPHOSPHAMIDE (268) DOXORUBICIN (215) ADALIMUMAB (214) ONDANSETRON (202) RITUXIMAB (197) DEXAMETHASONE (196) PACLITAXEL (189)

Which APREPITANT Alternatives Have Lower Atelectasis Risk?

APREPITANT vs APROTININ APREPITANT vs ARANESP APREPITANT vs ARAVA APREPITANT vs AREDIA APREPITANT vs ARFORMOTEROL

Related Pages

APREPITANT Full Profile All Atelectasis Reports All Drugs Causing Atelectasis APREPITANT Demographics